ResApp Health Limited, a digital health company, develops smartphone applications for the diagnosis and management of respiratory disease. It offers digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease. The company has both adult and paediatric clinical studies underway with preliminary results demonstrating accurate diagnosis of pneumonia, asthma/viral wheeze, bronchiolitis, croup, and upper respiratory tract infections in children, as well as chronic obstructive pulmonary disease, asthma, and pneumonia in adults. The company was formerly known as Narhex Life Sciences Limited and changed its name to ResApp Health Limited.